Gout overview: Difference between revisions
| Line 13: | Line 13: | ||
===Historical Perspective=== | ===Historical Perspective=== | ||
* Gout was first described by Egyptians in 2640 BC. | |||
* Hippocrates described [[podagra]] in 5th century BC as the unwalkable disease.<ref name="pmid16820040">{{cite journal| author=Nuki G, Simkin PA| title=A concise history of gout and hyperuricemia and their treatment. | journal=Arthritis Res Ther | year= 2006 | volume= 8 Suppl 1 | issue= | pages= S1 | pmid=16820040 | doi=10.1186/ar1906 | pmc=3226106 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16820040 }} </ref> | |||
* Galen described the [[monosodium urate]] crystal deposition following long standing [[hyperuricemia]] as [[Tophi]] | |||
[[Aulus Cornelius Celsus]] appeared to recognize many of the features of gout. [[Galen]] described gout as a discharge of the four [[Four Temperaments|humors]] of the body in unbalanced amounts into the joints. | [[Aulus Cornelius Celsus]] appeared to recognize many of the features of gout. [[Galen]] described gout as a discharge of the four [[Four Temperaments|humors]] of the body in unbalanced amounts into the joints. | ||
Revision as of 18:10, 19 May 2020
| https://https://www.youtube.com/watch?v=bznoU5bke4U%7C350}} |
|
Gout Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gout overview On the Web |
|
American Roentgen Ray Society Images of Gout overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Gout, otherwise called as metabolic arthritis is a congenital disorder of Uric acid metabolism. In this condition, monosodium urate or uric acid crystals are deposited on the articular cartilage of joints, tendons and surrounding tissues due to elevated concentrations of uric acid in the blood stream. This provokes an inflammatory reaction of these tissues. These deposits often increase in size and burst through the skin to form sinuses discharging a chalky white material.
Historical Perspective
- Gout was first described by Egyptians in 2640 BC.
- Hippocrates described podagra in 5th century BC as the unwalkable disease.[1]
- Galen described the monosodium urate crystal deposition following long standing hyperuricemia as Tophi
Aulus Cornelius Celsus appeared to recognize many of the features of gout. Galen described gout as a discharge of the four humors of the body in unbalanced amounts into the joints.
Pathophysiology
Gout occurs when mono-sodium urate crystals form on the articular cartilage of joints, on tendons, and in the surrounding tissues. Purine metabolism gives rise to uric acid, which is normally excreted in the urine. Defects in the kidney may cause uric acid to build up in the blood, leading to hyperuricemia, and the subsequent formation of gout crystals.
Differentiating Gout from other Diseases
Gout needs to be differentiated from other diseases such as cellulitis, rheumatoid arthritis, septic arthritis and sarcoidosis as they present with similar symptoms.
Epidemiology and Demographics
Gout affects men in age group 40-50 years. It is more common in people from the Pacific Islands, and New Zealand. In the United States, gout is twice as prevalent in African American males as it is in Caucasians.
Risk Factors
Several factors may put a person at risk for developing gout. These include the presence of; hypertension, diabetes, hypercholesterolemia, obesity, and alcohol abuse. Certain medications may also put a person at a higher risk for developing gout.
Prognosis
The prognosis of gout is good if it is treated early, and if the person maintains a healthy lifestyle with modification of their individual risk factors.
Diagnosis
Symptoms
The classic picture of an acute gouty attack, is sudden, excruciating, unexpected and burning pain. There will also be swelling, redness, warmth, and stiffness in the joint. In approximately 75% of first episodes, gout usually attacks the big toe.
Laboratory Findings
A definitive diagnosis of gout is made from light microscopy of the fluid aspirated from the joint. The fluid demonstrates intracellular negatively bi-refringent monosodium urate crystals and polymorphonuclear leukocytes in the synovial fluid. Although hyperuricemia is a common feature of gout, a high uric acid level does not necessarily mean a person will develop gout.
X-ray
An x-ray is done when gout is suspected to rule out other abnormalities of the bone that may be causing the pain. Most commonly in gout, the x-ray will show no abnormalities, or a small amount of soft tissue swelling.
Treatment
Medical Therapy
The first goal of therapy when treating gout, is pain relief. This can be acheived with NSAIDs, and oral or intra-articular glucocorticoids. If colchicine is given, it should be taken within the first 12 hours of the attack. Other, less standard methods of treatment include the use of hemorrhoidal ointment, ice, increasing mobility, and acetazolamide.
Surgery
For extreme cases of gout, surgery may be necessary to remove large tophi and correct joint deformity.
Secondary Prevention
There are several methods used to prevent a re-occurrence of gout. Dietary changes include reducing the intake of foods that increase the levels of purine in blood, such as protein and alcohol. Several foods, and vitamin C have been thought to decrease the levels of purine in the blood. Modification of the risk factors for gout has been shown to also be beneficial in reducing the reoccurrence of gout. There are medications which can increase the excretion of uric acid, and reduce uric acid levels through other mechanisms.
References
- ↑ Nuki G, Simkin PA (2006). "A concise history of gout and hyperuricemia and their treatment". Arthritis Res Ther. 8 Suppl 1: S1. doi:10.1186/ar1906. PMC 3226106. PMID 16820040.